Skip to content

NAC effect on late remodeling

Evaluating the effect of N-acetyl cysteine on the Late Remodeling’s Biomarkers and ecocargdiography parameters in patients following acute myocardial infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201211168698N3
Enrollment
100
Registered
2012-12-14
Start date
2012-12-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction. Acute Myocardial Infarction

Interventions

Intervention 1: Intervention: Bolus dose of NAC 100 mg/kg then 10 mg/kg/hr for 12 hours- During the intervention NAC will be administered intracoronary. Intervention 2: Control group: Receive D5W in t
Treatment - Drugs
Placebo
Intervention: Bolus dose of NAC 100 mg/kg then 10 mg/kg/hr for 12 hours- During the intervention NAC will be administered intracoronary
Control group: Receive D5W in the same volume as NAC

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria:Myocardial infarction patients who were candidate of primary PCI . Exclusion Criteria:rescue pci; emergency for cardiac bypass ; cardiogenic shock; life expactancy less than 6 months; Age less than 18 years old; Uncontrolled hypertension; Thrombocytopenia; Malformation or aneurysm; sever chronic renal failure; Sever liver failure; sensitivity to sulfonamides ; Major surgery; Unsatisfactory to enter to study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Echocardiography findings of remodeling (LVEDV). Timepoint: Baseline and after a month. Method of measurement: Echocardiography.

Secondary

MeasureTime frame
Level of MMP-9. Timepoint: Baseline and after a month. Method of measurement: Serum level-Elisa kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzita Hajhossein Talasaz

Tehran University of Medical Sciences

atalasaz@razi.tums.ac.ir+98 21 6695 4709

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026